Check Your Claims Before Reviewers Do

 Quick Explanation Copied

 Long Explanation

Who is this author? Disambiguation first

The name "James A. Cotton" maps to multiple scientists. The dominant profile (OpenAlex A5034286182, ORCID 0000-0001-5475-3583) is James Anthony Cotton, an evolutionary biologist at the Wellcome Sanger Institute, with 232 works, 11,274 citations, and h-index 58 Parasitic worm comparative genomics. A smaller homonym profile (h-index 10, 811 citations, ORCID 0000-0002-3264-4244) and the sparse h-index-8 Semantic Scholar-style profile (608 citations, 52 papers including cardiology, Barrett's oesophagus, and unrelated editorial topics) reflect separate individuals. Notably, many of the supplied research records (cotton agronomy, textile yarns, wound dressing packs) are about the crop, not the author, and provide no evidence about this researcher.

Citation trajectory

Peak citation years (2011: 1,010; 2013: 1,671) correspond to high-impact parasite genomics and phylogenetics work, including whole-genome sequencing of Leishmania donovani isolates (431 citations) and convergent evolution in echolocating mammals (378 citations) Leishmania drug-resistance genomics Convergent evolution in echolocators.

Core scientific strengths (from directly attributed work)

• Phylogenetic methodology with critical self-scrutiny. His genome-phylogeny comparison across 22 archaeal genomes (14,673 gene families filtered to 594 informative alignments) demonstrated that conditioned reconstruction carries systematic conditioning-genome bias and that genome-scale trees are method-dependent — a methodologically honest, negative-leaning result rare in the field Genome phylogeny method comparison.
• Macroevolutionary inference from tree shape. Analysis of 715 human gene-family trees showed strong imbalance versus Equal-Rate Markov expectations (χ² 1693.9, df 1430, p < 0.0001; 73% of four-member families unbalanced, binomial p = 0.0055), implicating tandem duplication/loss over genome duplications Gene family tree balance analysis.
• Translational parasite genomics. Senior involvement in characterizing Δ7-dafachronic acid as the endogenous Ss-DAF-12 ligand in Strongyloides stercoralis, with CRISPR validation of Ss-cyp22a9 and gerbil-model synergy with ivermectin (~70% survival alone; >75% combined, near-complete cure) Strongyloides DAF-12 ligand and anthelmintic strategy, plus leading authorship of the Globodera pallida genome paper Cyst nematode genome paper.

Blind spots and uncertainties

• Position profile: In nearly all top works he is a middle author; first/senior leadership appears in fewer outputs (e.g., G. pallida), so independent scientific vision is harder to gauge from citation counts alone.
• Declining recent output: 2023–2026 shows only 2–27 works/year with sharply falling citations (53, 96, 22, 6), suggesting either a shift to less-cited venues, roles in large consortia, or data-lag — unknown from these sources.
• Identity contamination: Merged homonym records (cardiology, emergency nursing, agronomy) would inflate apparent breadth if not filtered; score assignments to ambiguous records are unreliable.
• Age of methodological work: The 2006/2008 phylogenetics papers predate modern coalescent/ASTRAL-era methods; conclusions should be re-evaluated against current tooling rather than taken as current best practice.

Confidence: Moderate-high on the core profile (multiple converging attributed works and OpenAlex metrics); moderate on disambiguation, since institution fields are missing and homonymy is extensive. Evidence that would change this assessment: confirmation that the h-58 profile conflates multiple people, or first/senior-authorship records showing different scientific leadership patterns.

 BGPT Author Review

Scientific Quality

A genuinely strong evolutionary genomicist: h-index 58 and >11,000 citations on a 232-work corpus spanning parasite genomics, phylogenetics methodology, and macroevolution. His methodological papers show commendable self-critical rigor (demonstrating bias in his own field's methods rather than overclaiming). Main caveats: mostly middle authorship on the most-cited works, thin recent output, and severe homonym contamination muddying attribution.

Communication Quality

Papers are published in high-quality, readable venues with clear problem framing and explicit limitations sections (e.g., openly reporting conditioning-genome bias). Numerous perspective/review pieces suggest active science communication. No evidence of textbook-level or public-facing communication was available; EMG/biomechanics-style dense quantitative reporting limits lay accessibility.

Author Novelty

Contributed genuinely novel methodological critiques (conditioned-reconstruction bias, gene-family tree balance as a duplication-mode signal) and co-drove first-of-kind parasite genome resources. However, much output is consortium-scale descriptive genomics where novelty is distributed and incremental; true paradigm-shifting originality is not evident.

Scientific Rigor

Rigor is well-supported: formal null-model testing (ERM/PDA chi-squared analyses with code released), 100-bootstrap robustness checks, CRISPR-based genetic validation in the Strongyloides work, and candid limitations sections throughout. Deductions for small-n clinical/gerbil studies, non-randomized designs in attributed clinical work, and reliance on simplifying null models in tree-shape analysis.